Canna Clinicals

Data Snapshot: Apr 04, 2024
Canna Clinicals Cannabis Brand Logo
<$50K

Mar-2024

Sales

Strong Growth

Trend

6-Month

4

Product Count

SKUs

Canna Clinicals

Overview

Markets

Canna Clinicals Locations

Product Trends

Canna Clinicals Categories

Canna Clinicals Sales

Market Insights Snapshot

Canna Clinicals Historical Sales by Category

In New York, Canna Clinicals has shown a notable presence in the cannabis market, especially in the Capsules and Tincture & Sublingual categories. Their performance in the Capsules category has been consistently strong, maintaining a top 5 position from December 2023 through March 2024, and even improving their rank from 5th to 4th place by March 2024. This upward movement is particularly impressive, reflecting a growing consumer preference for their capsules, underscored by a significant increase in sales from 320 units in December 2023 to 2095 units in March 2024. However, the brand's journey in the Tincture & Sublingual category tells a slightly different story. Initially, they were not ranked in the top 30 brands for December 2023, indicating a potential gap in market penetration or consumer awareness. Yet, they quickly turned this around by securing the 7th position by January 2024 and maintaining a strong presence with a 6th place ranking in the subsequent months, showcasing a remarkable recovery and growth in this category.

The performance of Canna Clinicals across these categories in New York not only highlights their market resilience but also points to strategic areas of focus and opportunity. The absence from the top 30 rankings in the Tincture & Sublingual category in December 2023 could have been a wake-up call, but the rapid ascent to the 6th rank by February 2024 demonstrates their ability to effectively respond to market demands. This is further evidenced by their impressive sales figures in this category, jumping from no sales reported in December 2023 to 10,622 units by March 2024. Such data points suggest that Canna Clinicals has not only identified but also successfully capitalized on consumer trends and preferences within the New York market. While the detailed strategies behind these movements are not disclosed, the observed trends and rankings offer valuable insights into the brand's operational focus and market performance.

Mar-2024 Rank
Capsules
Tincture & Sublingual
4
6
Canna Clinicals

Competitive Landscape

In the competitive landscape of the Tincture & Sublingual category in New York, Canna Clinicals has shown a promising upward trajectory in terms of rank and sales from January 2024 to March 2024, moving from not being in the top 20 in December 2023 to securing the 6th position by March 2024. This growth is notable when compared to its competitors, such as Veterans Choice Creations (VCC), which experienced a decline from the 4th to the 7th position in the same period. Meanwhile, OMO - Open Minded Organics has seen significant growth, moving from the 6th to the 4th position, with a remarkable increase in sales. On the other hand, Harney Brothers Cannabis and House of Puff have shown fluctuating ranks but overall positive momentum, with House of Puff jumping significantly from the 13th to the 8th position. Canna Clinicals' steady rise in both rank and sales amidst these fluctuations among competitors highlights its growing foothold and potential challenges in capturing a larger market share in the New York Tincture & Sublingual market.

Canna Clinicals market ranking for NY Tincture & Sublingual

Canna Clinicals

Notable Products

In Mar-2024, Canna Clinicals saw the CBD/THC 1:10 Max Strength Tincture (100mg CBD, 1000mg THC, 30ml) as its top-selling product, maintaining its number one rank since Jan-2024, with notable sales reaching 125 units. Following closely, the Max Strength Capsules 10-Pack (100mg CBD, 100mg THC) secured the second position consistently from Jan-2024 to Mar-2024. The CBD/THC/CBN 1:1:1 Sleep Complex Capsules 20-Pack (100mg CBD, 100mg THC, 100mg CBN) and the CBD/THC/CBG 1:1:1 Relief Complex Capsules 20-Pack (100mg CBD, 100mg THC, 100mg CBG) were ranked third and fourth, respectively, showing stability in their positions over the past three months. Interestingly, the sales figures indicate a growing consumer preference for products with a balanced blend of cannabinoids. This trend is evident from the steady ranking and sales growth of the top products, highlighting a consistent demand for specific cannabinoid formulations.

Product Rank
Category
Dec-2023
Jan-2024
Feb-2024
Mar-2024
CBD/THC 1:10 Max Strength Tincture (100mg CBD, 1000mg THC, 30ml)
Tincture & Sublingual
>5
1
1
1
Max Strength Capsules 10-Pack (100mg CBD, 100mg THC)
Capsules
1
2
2
2
CBD/THC/CBN 1:1:1 Sleep Complex Capsules 20-Pack (100mg CBD, 100mg THC, 100mg CBN)
Capsules
2
3
3
3
CBD/THC/CBG1:1:1 Relief Complex Capsules 20-Pack (100mg CBD, 100mg THC, 100mg CBG)
Capsules
3
4
4
4
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you. Try any plan free for 30 days.
Research the top cannabis brands across markets in the US and Canada.
Header image
User rating
start Today
Connect to Headset

Get Cannabis Market Data